Skip to content

    Journey Medical (DERM) stock price & financials

    View DERM earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance0.1% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $14.63M
    $13.62M
    $13.14M
    $15.01M
    $17.63M
    +20.5%
    $16.08M
    +18.1%
    $15.96M
    +21.5%
    $18.51M
    +23.3%
    Strengthening
    Operating Profit
    -$2.89M
    $2.23M
    -$3.32M
    -$2.88M
    -$1.53M
    +47.2%
    -$443.0K
    -119.8%
    -$1.49M
    +55.1%
    $456.0K
    Weakening
    Net Profit
    -$2.39M
    $1.52M
    -$4.07M
    -$3.80M
    -$2.31M
    +3.1%
    -$1.25M
    -182.0%
    -$2.23M
    +45.2%
    -$312.0K
    +91.8%
    Weakening
    EPS
    $-0.12
    $-0.18
    $-0.16
    $-0.09
    +25.0%
    $-0.08
    +55.6%
    $-0.01
    +93.8%
    Strengthening
    Other Income
    $504.0K
    -$652.0K
    -$749.0K
    -$860.0K
    -$786.0K
    -256.0%
    -$804.0K
    -23.3%
    -$738.0K
    +1.5%
    -$753.0K
    +12.4%
    Weakening
    Interest
    $758.0K
    $831.0K
    $891.0K
    $937.0K
    $937.0K
    +23.6%
    $933.0K
    +12.3%
    $892.0K
    +0.1%
    $906.0K
    -3.3%
    Strengthening
    Depreciation
    Profit before Tax
    -$2.39M
    $1.58M
    -$4.07M
    -$3.74M
    -$2.31M
    +3.1%
    -$1.25M
    -178.8%
    -$2.23M
    +45.2%
    -$297.0K
    +92.1%
    Weakening
    MarginsOPM
    -19.8%
    16.4%
    -25.3%
    -19.2%
    -8.7%
    +56.2%
    -2.8%
    -116.8%
    -9.3%
    +63.0%
    2.5%
    Weakening
    Tax
    -1.6%
    -5.0%
    -213.7%
    Weakening
    ReturnsROIC
    2.4%
    -1.5%
    4.0%
    3.8%
    2.3%
    -3.1%
    1.2%
    2.2%
    -45.2%
    0.3%
    -91.8%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$8.25M$49.08M$32.00M$27.44M$20.30M$24.09M$25.64M
    Short-Term Investments
    Total Current Assets$35.24M$84.49M$77.68M$56.45M$48.18M$66.87M$72.78M
    Net PP&E$175.0K$89.0K$189.0K$101.0K$199.0K$111.0K$65.0K
    Goodwill
    Intangibles$15.03M$12.55M$27.20M$20.29M$31.86M$27.61M$25.51M
    Total Assets$51.91M$97.28M$105.16M$76.85M$80.24M$94.59M$98.36M
    LiabilitiesTotal Current Liabilities$28.06M$51.61M$66.83M$41.87M$35.17M$37.44M$45.77M
    Short-Term Debt$5.00M
    Long-Term Debt$19.83M$14.62M$24.88M$25.28M$20.47M
    Long-Term Leases$97.0K$108.0K$9.0K$118.0K$18.0K
    Total Liabilities$41.61M$55.24M$88.18M$56.50M$60.17M$62.74M$66.24M
    EquityCommon Stock & APIC
    Retained Earnings$5.12M-$38.87M-$68.50M-$72.36M-$87.03M-$98.46M-$101.00M
    Total Equity$10.29M$42.04M$16.98M$20.35M$20.07M$31.85M$32.11M
    HighlightsNet Cash / (Debt)$171.0K

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating$5.13M-$2.18M-$13.53M$5.24M-$9.13M-$12.44M-$7.49M
    Cash from Investing-$1.20M-$10.00M-$20.00M-$5.00M-$15.00M
    Cash from Financing-$487.0K$53.02M$16.46M-$4.80M$16.99M$16.23M$12.84M
    SummaryCapital Expenditure-$20.00M-$5.00M-$15.00M
    Free Cash Flow-$33.53M$240.0K-$24.13M
    FCF Margin-45.5%0.3%-43.0%

    Ratios